Regulators Approve Medical Isotope Hot Cell Facility at Bruce Power
The facility will process irradiated materials on site and support lutetium-177 production for cancer therapies while reducing emissions and transit requirements.
4 Articles
4 Articles
Final approval for Bruce Power's new Hot Cell facility
Bruce Power is expected to launch commercial operations in September at its new on-site Hot Cell facility in Kincardine.Bruce Power has received regulatory approval from the Canadian Nuclear Safety Commission to perform Target Carrier Removal directly on site.The specialized hot cell facility uses remote-handling technology to process irradiated materials while protecting staff from radiation exposure. Specifically, it will handle a key step in …
Bruce Power receives CNSC approval to operate on-site hot cell facility
Bruce Power has received approval from the Canadian Nuclear Safety Commission (CNSC) to operate its on-site hot cell facility, marking a significant milestone in the company’s continued leadership in the production of cancer-fighting medical isotopes. The CNSC’s approval authorizes Bruce Power to use the facility to perform Target Carrier Removal (TCR), an important step in the production process for lutetium-177 (Lu-177), a medical isotope used…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium






